| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |